κ阿片受体激动剂抑制Kiss1神经元治疗多囊卵巢综合征与血管舒缩症状
该研究在模拟绝经和多囊卵巢综合征(PCOS)的两种小鼠模型中,使用外周限制性κ受体激动剂(PRKA)抑制过度活跃的KNDy神经元。结果显示,PRKA可降低去卵巢小鼠的体温和LH水平,并抑制PCOS小鼠的LH和睾酮水平、恢复卵巢周期,提示其可能成为治疗血管舒缩症状和PCOS的新方法。
要点
- PRKA抑制KNDy神经元可降低去卵巢小鼠升高的体温和LH水平。
- PRKA抑制PCOS小鼠的LH和睾酮水平并恢复卵巢周期。
- 抑制Kisspeptin神经元活性可能是治疗VMS和PCOS的新策略。
核心结论
- 通过激活κ受体抑制kisspeptin神经元活性,有望成为治疗人类血管舒缩症状和PCOS的新方法。
研究设计与样本
- 研究设计为病例对照,在学术医疗中心进行,使用小鼠作为研究对象。
主要发现
- 在双侧卵巢切除并实验性诱导KNDy神经元过度活跃的小鼠中,长期给予PRKA可降低动物升高的体温、平均血浆LH水平和每脉冲平均LH峰值。
- 在血浆睾酮升高且卵巢周期不规则的PCOS小鼠模型中,长期给予PRKA可抑制循环LH和睾酮水平,并恢复正常的卵巢周期性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Recent evidence suggests that vasomotor symptoms (VMS) or hot flashes in the postmenopausal reproductive state and polycystic ovary syndrome (PCOS) in the premenopausal reproductive state emanate from the hyperactivity of Kiss1 neurons in the hypothalamic infundibular/arcuate nucleus (KNDy neurons). OBJECTIVE: We demonstrate in 2 murine models simulating menopause and PCOS that a peripherally restricted kappa receptor agonist (PRKA) inhibits hyperactive KNDy neurons (accessible from outside the blood-brain barrier) and impedes their downstream effects. DESIGN: Case/control. SETTING: Academic medical center. PARTICIPANTS: Mice. INTERVENTIONS: Administration of peripherally restricted kappa receptor agonists and frequent blood sampling to determine hormone release and body temperature. MAIN OUTCOME MEASURES: LH pulse parameters and body temperature. RESULTS: First, chronic administration of a PRKA to bilaterally ovariectomized mice with experimentally induced hyperactivity of KNDy neurons reduces the animals' elevated body temperature, mean plasma LH level, and mean peak LH per pulse. Second, chronic administration of a PRKA to a murine model of PCOS, having elevated plasma testosterone levels and irregular ovarian cycles, suppresses circulating levels of LH and testosterone and restores normal ovarian cyclicity. CONCLUSION: The inhibition of kisspeptin neuronal activity by activation of kappa receptors shows promise as a novel therapeutic approach to treat both VMS and PCOS in humans.
引用
- McCarthy EA, Dischino D, Maguire C, et al. Inhibiting Kiss1 Neurons With Kappa Opioid Receptor Agonists to Treat Polycystic Ovary Syndrome and Vasomotor Symptoms. J Clin Endocrinol Metab. 2022. PMID: 34387319. doi:10.1210/clinem/dgab602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。